Skip to main content

Table 2 Modelled incidence (acute infections per 100,000) by age-group in the years 2000 and 2030

From: Effects of an ageing population and the replacement of immune birth cohorts on the burden of hepatitis A in the Netherlands

Age group (years) Incidence in 2000 (95% CI) Incidence in 2030 (95% CI)
<1 5.1 (2.5–7.9) 1.8 (0.48–3.1)
1-4 24.4 (21.1–27.6) 2.1 (1.2–3.0)
5-9 43.1 (39.3–47.1) 2.8 (1.9–3.8)
10-14 29.9 (26.7–33.1) 2.4 (1.5–3.2)
15-19 13.0 (10.7–15.2) 1.8 (1.0–2.5)
20-24 4.8 ( 3.6–6.0) 1.5 (0.89–2.2)
25-29 4.7 (3.6–5.9) 1.6 (0.93–2.2)
30-34 4.8 (3.7–5.8) 1.6 (0.89–2.2)
35-39 8.5 (7.1–9.9) 1.7 (1.1–2.4)
40-44 5.5 (4.3–6.7) 1.6 (0.97–2.3)
45-49 4.8 (3.7–6.0) 1.6 (0.90–2.2)
50-54 3.5 (2.5–4.4) 1.5 (0.79–2.1)
55-59 2.3 (1.4–3.3) 1.4 (0.79–2.0)
60-64 2.8 (1.7–3.9) 1.4 (0.80–1.9)
65-69 3.4 (2.1–4.6) 1.1 (0.59–1.6)
70-74 2.3 (1.2–3.4) 0.88 (0.39–1.3)
75-79 1.8 (0.87–2.9) 0.72 (0.27–1.2)
80-84 1.9 (0.68–3.2) 0.50 (0.15–0.87)
85+ 1.9 (0.56 –3.2) 0.34 (0.08–0.60)